Maybe they think you've been ramping too much.
in their defense, looking at it from a lay perspective, this isn't entirely relevant to our core strategy ie cancer(I realise it further reaffirms FTO in a human's overall disease process). And it isn't a new finding per se, as we know zantrene and FTO is linked(twice already independently).
While I agree it further reaffirms the Zantrene and FTO link, from what I can see, diabetes isn't on the cards for any clinical trials. A lot of posters here have been prematurely excited off this paper, but there is still a lot of work to be done before there would be a tangible return, IMO.
with that said, you did say you deemed it as not price sensitive, so I'm not sure how it's ramping.
This from a non scientific POV, Dr T.. I'm happy for you to correct me if you think otherwise.
- Forums
- ASX - By Stock
- RAC
- Ann: Quarterly Activity Report & Appendix 4C
Ann: Quarterly Activity Report & Appendix 4C, page-23
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M |
Open | High | Low | Value | Volume |
$1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1996 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 1305 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4387 | 1.600 |
1 | 31000 | 1.590 |
1 | 10000 | 1.585 |
2 | 8233 | 1.560 |
4 | 15571 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.690 | 585 | 1 |
1.700 | 17181 | 1 |
1.750 | 30400 | 2 |
1.755 | 990 | 1 |
1.820 | 1000 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |